• Immunovant, Inc. (NASDAQ:IMVT) Given Consensus Rating of "Buy" by Analysts

    Источник: Buzz FX / 05 окт 2024 03:29:10   America/Chicago


    Immunovant, Inc. (NASDAQ:IMVT) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat October 5, 2024 Share Link copied to clipboard. Shares of Immunovant, Inc. ( NASDAQ:IMVT - Get Free Report ) have been assigned an average reco
    Read more...
Опубликовать